Reports for APOTEX INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

250 (7%)

Anticipated shortage:

3 (0%)

Avoided shortage:

11 (0%)

Resolved:

3299 (93%)

3563

Discontinuation Reports

To be discontinued:

24 (7%)

Discontinued:

342 (93%)

Reversed:

0 (0%)

366

143 (4%)

32 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-VARENICLINE 0.5MG 1MG KIT TABLET Resolved 2020-09-02 2020-09-14 123589
APO-VARENICLINE 1MG TABLET Resolved 2021-05-07 2025-01-31 138992
APO-VARENICLINE 1MG TABLET Resolved 2024-08-09 2024-08-23 234996
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2019-07-02 86347
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-06-12 2022-05-16 86341
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2019-07-17 2020-07-10 89554
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-07-17 2019-11-25 89557
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2018-05-31 2019-05-31 50971
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2020-05-08 2021-03-09 114327
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2017-05-16 2018-03-08 10442
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2019-11-20 2019-11-25 99320
APO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-06-09 2023-08-18 194581
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Actual shortage 2023-06-23 2023-09-01 196306
APO-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Resolved 2022-09-01 2022-09-16 168356
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-09-01 2022-11-20 168353
APO-VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-09 2023-01-13 177618
APO-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Actual shortage 2022-07-29 2023-09-01 165727
APO-VENLAFAXINE XR 150MG CAPSULE (EXTENDED RELEASE) Actual shortage 2022-12-16 2023-08-18 178766
APO-VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Resolved 2020-01-22 2020-09-14 103926
APO-VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Resolved 2018-04-10 2018-11-03 45353
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE TABLETS 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-FLUVOXAMINE TABLETS 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971